上海一飞生物科技有限公司 Company Information
Company Name:
Shanghai Yifei Biotechnology Co. , Ltd.
Tel:
021-65675885
Email:
customer_service@efebio.com
Nationality:
China
WebSite:
http://www.efebio.com
Product List:
11973
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
Product List
BMS-599626 2HCL(714971-09-2 Free base)
1781932-33-9
Keliximab
174722-30-6
Sulesomab
167747-19-5
Flupyrimin
1689566-03-7
Obexelimab
1690307-05-1
Gosuranemab
1788032-39-2
Odronextamab
1801338-64-6
SB-237376
179258-59-4
RYL-552
1801444-56-3
WAY-639228
179051-05-9
Basiliximab
179045-86-4
AZ-PFKFB3-67
1704741-11-6
FK 866 hydrochloride (658084-64-1 free base)
1785666-54-7
BCAT-IN-2
1800024-45-6
GNE-0946
1677667-24-1
Porgaviximab
1792982-55-8
LDN-209929 dihydrochloride
1784281-97-5
PF-04822163
1798334-07-2
ABBV-318
1802848-94-7
PG 34
1681056-62-1
ARTD10/PARP10-IN-1
1708103-76-7
Tagatose
17598-81-1
UC-781
178870-32-1
Netakimab
1796570-08-5
KL044
1801856-93-8
MMP2-IN-2
1772-39-0
Faralimomab
167816-91-3
Igovomab
171656-50-1
RN-1665
1803003-65-7
NLRP3/AIM2-IN-3
1787787-60-3
Felvizumab
167747-20-8
Propofol-d17 β-D glucuronide
1683581-05-6
tert-Butyl (6-iodohexyl)carbamate
172846-36-5
SXC 2023
1695562-36-7
ML 120B dihydrochloride
1782573-78-7
Elezanumab
1791416-49-3
Larcaviximab
1792982-56-9
SR12418
1801185-08-9
Vutiglabridin
1800188-47-9
CCT245232
1693731-14-4
RYL-552S
1801444-69-8
ZY-444
1802650-31-2
Inophyllum E
17312-31-1
Anisperimus
170368-04-4
SR4554
167648-73-9
Sarizotan 2HCl
177976-12-4
Phenmedipham-d3
1773497-41-8
Rosmantuzumab
1684393-04-1
Emapalumab
1709815-23-5
ATX-002
1777792-34-3
Sodium zirconium cyclosilicate
17141-74-1
Oleoylestrone
180003-17-2
1-vinylpyrene
17088-21-0
GSK180
1799725-26-0
GNF6702
1799329-72-8
(E)-3-(2-Chloro-4-fluorophenyl)acrylic acid
174603-37-3
Cynandione A
168706-29-4
Frunevetmab
1708936-80-4
Cemiplimab
1801342-60-8
3,4,5-Trihydroxycinnamic acid decyl ester
1770778-45-4
Piprozolin
17243-64-0
SB-237376 HCl
179258-62-9
CYP1B1-IN-5
176442-56-1
BODIPY FL prazosin
175799-93-6
YM-58790
168830-70-4
Izonsteride
176975-26-1
Tidembersat
175013-73-7
Nav1.7-IN-3
1788872-06-9
Remtolumab
1791410-27-9
Lutikizumab
1791411-57-8
Telisotuzumab
1781223-80-0
Oleclumab
1803176-05-7
Cevidoplenib
1703788-21-9
DJ4
1681020-24-5
Nonabine
16985-03-8
Lanepitant 2HCl
170508-05-1
DP00477
169120-56-3
Roxifiban acetate
176022-59-6
(2R,5S)-Ritlecitinib
1792180-79-0
Ravulizumab
1803171-55-2
αvβ1 integrin-IN-1
1689540-62-2
Sacituzumab
1796566-95-4
Crizanlizumab
1690318-25-2
Cosfroviximab
1792982-57-0
Gremubamab
1800381-36-5
(R)-VX-11e
1680187-43-2
ER-34122
179325-62-3
Xanthine amine congener hydrochloride
1783977-95-6
Thalidomide-O-amido-CH2-PEG3-CH2-NH-Boc
1799711-31-1
Dyrk1A-IN-5
1685235-41-9
Lanepitant
170566-84-4
Opaviraline
178040-94-3
NLRP3-IN-13
1704638-35-6
RKI-1447 dihydrochloride
1782109-09-4
NDH-1 inhibitor-1
173964-49-3
GPR40 agonist 6
1798751-25-3
Vunakizumab
1792181-33-9
Losatuxizumab
1801544-27-3
Dilpacimab
1791420-09-1
Minzasolmin
1802518-92-8
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
Copyright 2007© ChemicalBook. All rights reserved.